Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis is shutting down Colorado plant, laying off 400 employees after overestimating gene therapy demand
Fierce Pharma
Thu, 03/25/21 - 11:18 am
Tags:
Novartis, gene therapy, layoffs, Colorado, drug manufacturing
Novartis' radioligand hits goal in phase 3 prostate cancer trial
Fierce Biotech
Tue, 03/23/21 - 10:29 am
Tags:
Novartis, radioligand, 177Lu-MSMA-617, prostate cancer, clinical trials
J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in crowded MS market
Fierce Pharma
Fri, 03/19/21 - 10:56 am
Tags:
JNJ, Ponvory, Novartis, Bristol-Myers Squibb, MS, multiple sclerosis
Are radiopharmaceuticals ready for the mainstream? Novartis, Bristol Myers Squibb bet yes on MPM's platform take
Endpoints
Thu, 03/18/21 - 10:51 am
Tags:
MPM Capital, radiopharmaceuticals, Novartis, Bristol Myers Squibb
Eli Lilly, Novartis back a biotech startup boasting 'best of both worlds' protein degraders
Endpoints
Wed, 03/17/21 - 10:30 am
Tags:
Eli Lilly, Novartis, protein degradation, Amphista
Novartis’ Autoimmune Drug Not Up for the Challenge in Phase III Cancer Trial
BioSpace
Tue, 03/9/21 - 09:47 pm
Tags:
Novartis, canakinumab, clinical trials, metastatic non-small cell lung cancer
Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity
Endpoints
Tue, 03/9/21 - 10:49 am
Tags:
Novartis, generics, Sandoz, FDA, Aubagio, multiple sclerosis, MS
Setback for Novartis drug in advanced lung cancer trial
Biopharma Reporter
Tue, 03/9/21 - 10:40 am
Tags:
Novartis, clinical trials, canakinumab, metastatic non-small cell lung cancer
Novartis exec says Kymriah's ready to square off with Bristol Myers' new CAR-T rival Breyanzi
Fierce Pharma
Sun, 03/7/21 - 01:29 pm
Tags:
Bristol Myers Squibb, Breyanzi, CAR-T, lymphoma, Novartis, Kymriah
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda
Fierce Pharma
Thu, 03/4/21 - 11:21 pm
Tags:
Pfizer, Lorbrena, non-small cell lung cancer, Novartis, Roche, Takeda
Two biotechs target dry eye disease after Novartis’ Xiidra problems
Pharmaforum
Thu, 03/4/21 - 09:57 am
Tags:
dry eye disease, Novartis, Xiidra, Sylentis, Azura Ophthalmics
Novartis pairs up with CureVac to help drive Covid-19 shot production but may miss the show in the US, EU
Endpoints
Thu, 03/4/21 - 09:48 am
Tags:
Novartis, vaccines, CureVac, COVID-19, drug manufacturing
Novartis study: Nurses and MS patients give thumbs-up to Kesimpta for ease of use
Fierce Pharma
Wed, 03/3/21 - 10:58 am
Tags:
Novartis, Kesimpta, MS, multiple sclerosis
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales
Fierce Pharma
Mon, 02/22/21 - 10:49 am
Tags:
Novartis, executive pay, Vas Narasimhan, Pharma CEOs, pandemic, COVID-19
A month after multi-billion dollar Novartis deal, BeiGene follows up with 'reverse' deal
Endpoints
Thu, 02/18/21 - 10:40 am
Tags:
BieGene, Novartis, Boston Immune Technologies, TNFR2
Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world
Stat
Wed, 02/17/21 - 10:41 am
Tags:
Novartis, Gates Foundation, gene therapy, sickle cell disease
Novartis’ blockbuster heart med Entresto snags FDA approval in larger patient group
Fierce Pharma
Tue, 02/16/21 - 11:40 pm
Tags:
Novartis, Entresto, heart failure, labeling, FDA
GlaxoSmithKline to shut down antibiotics production, cut 300 jobs in wake of Novartis buyout
Fierce Pharma
Fri, 02/12/21 - 11:09 am
Tags:
GSK, Novartis, Sandoz, layoffs, antibiotics, drug manufacturing
Novartis’s canakinumab cancer test approaches
EP Vantage
Fri, 02/12/21 - 11:06 am
Tags:
Novartis, Regeneron, canakinumab, cancer, non-small cell lung cancer
Novartis' Sandoz doubles down on antibiotics with $500M deal for GSK brands
Fierce Pharma
Thu, 02/11/21 - 10:26 pm
Tags:
Novartis, Sandoz, generics, antibiotics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.